Role of endothelin-A receptors in ischemic contracture and reperfusion injury.
Open Access
- 3 February 1998
- journal article
- other
- Published by Wolters Kluwer Health in Circulation
- Vol. 97 (4) , 391-398
- https://doi.org/10.1161/01.cir.97.4.391
Abstract
Background —Circulating endothelin (ET)-1 is elevated in ischemia/reperfusion and may exert proischemic effects. The aim of the present study was to characterize the effects of ET-1 in rat isolated hearts using subtype-selective ET receptor antagonists, agents modulating the cytosolic Ca 2+ concentration, or the activity of cGMP-dependent protein kinase. Methods and Results —Rat hearts perfused at constant pressure were made ischemic by reducing flow to 0.2 mL · min -1 · g −1 , followed by reperfusion at normal pressure (each phase, 25 minutes). Drugs were infused during the ischemic phase only. Parameters monitored were extent and time-to-onset of contracture in ischemia, left ventricular developed pressure (LVDevP), coronary flow (CF), and diastolic relaxation during reperfusion. The ET A receptor-selective antagonist PD 155080 (50 nmol/L) reduced peak ischemic contracture (−49%) and delayed its time to onset (+56%) and improved recovery of reperfusion LVDevP (+12%), CF (+16%), and diastolic relaxation (+50%). Infusion of an ET A /ET B -nonselective antagonist, PD 142893 (200 nmol/L), had similar effects on all parameters, whereas infusion of BQ-788 (20 nmol/L), an ET B receptor-selective antagonist, was without effect. Exogenous ET-1 (100 pmol/L) hastened contracture and increased its extent (+23%) and reduced recovery of both LVDevP (−31%) and CF (−18%), effects that were counteracted by HOE 642 (10 μmol/L), a Na + /H + exchange inhibitor, but not by nicardipine (30 μmol/L), a Ca 2+ entry blocker; activation of cGMP-dependent protein kinase by the cell-permeable cGMP analog Sp-8-p-chlorophenylthioguanosine-3’,5’-cyclic monophosphorothioate (10 μmol/L) improved function without preventing the effects of ET-1. Conclusions —The data indicate that ET-1 exacerbates ischemic contracture and worsens ventricular and coronary reperfusion dysfunction by activating ET A receptors via a mechanism likely involving activation of Na + /H + exchange in this model.Keywords
This publication has 24 references indexed in Scilit:
- Role of ETB receptors in local clearance of endothelin‐1 in rat heart: studies with the antagonists PD 155080 and BQ‐788FEBS Letters, 1996
- Modulation of Endothelin-1 Effects on Rat Hearts and Cardiomyocytes by Nitric Oxide and 8-Bromo cyclic GMPJournal of Molecular and Cellular Cardiology, 1996
- Endothelin-1 contributes to ischemia/reperfusion injury in isolated rat heart?attenuation of ischemic injury by the endothelin-1 antagonists BQ123 and BQ610Journal of Molecular and Cellular Cardiology, 1995
- Coronary flow and glucose delivery as determinants of contracture in the ischemic myocardiumPublished by Elsevier ,1995
- Role of endothelin receptor subtype B(ET-B) in myocardial ischemiaLife Sciences, 1994
- (Rp)-8-pCPT-cGMPS, a novel cGMP-dependent protein kinase inhibitorEuropean Journal of Pharmacology: Molecular Pharmacology, 1994
- Plasma endothelin-1 in acute myocardial infarction with heart failureAmerican Heart Journal, 1993
- In Vitro and In Vivo Studies with a Series of Hexapeptide Endothelin AntagonistsJournal of Cardiovascular Pharmacology, 1993
- Ischaemia causes externalization of endothelin-1 binding sites in rat cardiac membranesBiochemical and Biophysical Research Communications, 1989
- Ischemic contracture of the myocardium: Mechanisms and preventionThe American Journal of Cardiology, 1977